EDGE MEDICAL-B: Yuanqian Gao Acquires Shares, Long Position Rises to 37.99%

HK Disclosure11-03

EDGE MEDICAL-B’s on-market repurchase of 119,200 H shares under its repurchase mandate on October 30, 2026 led to an increase in interest for Yuanqian Gao, who is deemed interested in the company’s treasury shares under the SFO; the buyback was executed on the SEHK open market at an average of HKD 31.2704 per share, involving about HKD 3.73 million, and although matched on the open market it was not a direct secondary-market dealing by the declarant.

Prior to the acquisition, Yuanqian Gao’s long position in EDGE MEDICAL-B was 124.39 million shares, representing 37.95%; following the acquisition, the holding changed to 124.51 million shares, with the long position ratio rising to 37.99%.

Source: Hong Kong Exchanges and Clearing Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment